Gefitinib modification of PEDOT:PSS increases inverted perovskite solar cell efficiency from 17.01% to 19.63% and improves long-term air stability.
Title resolution pending
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
fields
cond-mat.mtrl-sci 1years
2025 1verdicts
UNVERDICTED 1representative citing papers
citing papers explorer
-
Gefitinib-Induced Interface Engineering Enhances the Defect Formation Energy for Highly Efficient and Stable Perovskite Solar Cells
Gefitinib modification of PEDOT:PSS increases inverted perovskite solar cell efficiency from 17.01% to 19.63% and improves long-term air stability.